In the era of personalized medicine and personalized health there is a tremendous effort to bring NGS based technology in the clinical routine. Nevertheless, genome-wide information from research studies is in most cases useless in the clinical practice and in addition too expensive.
To bridge the gap between cancer research and clinical genomics, we propose PrecisionTrialDrawer, a suite of tools to explore the ability of cancer gene panels to be used in clinical trials.
What can you do with PTD?
Data
Design your panel and link it to specific tumor types
Create a Cancer Panel linking drugs to specific genes or alterations
Integrate genomic data like mutations, expression, copynumber and fusions
Use data from over 40 tumor types
Simulation
Calculate various measure of study feasibility
How many patients are covered by a specific mutations?
How many patients would be covered by a drug that acts on one or multiple targets?
Are the drugs covering overlapping pathways?
Power Analysis
Assure high power minimizing the number of patients to screen.
Innovative sample size calculation designed for genomic-driven clinical trials
Calculate sample size for a basket or umbrella trial with multiple drugs or tumor types
Given a power level to reach, analyze various simulation scenarios
Panel Design
Happy with the panel design?
Adjust gene size choosing what sequences to include